Latest News
In this issue:
- New Ways to Diagnose and Monitor Glaucoma
- President's Corner
- Gene for Repairing Retinal Cells Identified
- And More!
A team including two BrightFocus grantees has successfully transplanted a patch of retinal tissue into a patient with geographic atrophy. This experimental therapy was part of an NIH clinical trial and marks the first time in the U.S. that stem cells derived from a patient’s own tissue have been used to replace eye cells.
A new oral pill for geographic atrophy is being tested in an early-stage clinical trial.
Donald Weaver’s $1 million BrightFocus Centennial grant helped lead to his new exploration of Alzheimer’s roots, which he and colleagues have proposed may lie with an out-of-control autoimmune reaction.
The impact factor of Molecular Neurodegeneration, the official scientific journal of BrightFocus Foundation, has risen to 18.879, according to its publisher, up from 14.195 a year ago.
In this issue:
- President's Corner
- Researcher Spotlight: Laura Cox, PhD
- Study Explains Why Impact of Genetic Risk Factor Varies by Ancestry
- And more!
In this issue:
- President's Corner
- Parallels Found Between AMD Changes and Liver Cells
- How a High-Fat Diet Influences AMD
- And more!
In this Issue:
- Scientists Discover Key Gene Associated with Glaucoma
- President's Corner
- The Importance of Your Eye's Drainage System
- Spotlight On... Dr. Puya Gharahkhani, PhD
- And More!
In this issue:
- Researchers Discover Mechanisms Underlying Drusen Formation
- President's Corner
- Targeting Drusen Production in the Retina
- FDA Approves New Treatment for Macular Degeneration
- And more!
BrightFocus Foundation’s Alzheimer’s Disease Research program announced a request for scientific proposals for promising research on Alzheimer’s disease and related dementias. The application deadline is November 1, 2022, for projects beginning in 2023.
